We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current VERA market cap is 1.93B. The company's latest EPS is USD -2.1603 and P/E is -20.09.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -25.24M | -33.58M | -31.26M | -21.97M | -21.76M |
| Net Income | -24.68M | -32.44M | -30.07M | -20.16M | -20.1M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -11.96M | -52.24M | -34.4M | -90.9M | -102.01M |
| Net Income | -11.85M | -53.41M | -32.61M | -89.06M | -95.99M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 131.37M | 131.44M | 209.6M | 195.18M | 175.62M |
| Total Liabilities | 25.65M | 54.53M | 51.9M | 54.66M | 51.91M |
| Total Equity | 105.72M | 76.91M | 157.71M | 140.52M | 123.71M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 5.38M | 54.55M | 83.75M | 131.44M | 175.55M |
| Total Liabilities | 1.83M | 4.33M | 14.16M | 54.53M | 73.86M |
| Total Equity | -36.55M | -89.35M | 69.59M | 76.91M | 101.69M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -46.43M | -67.6M | -26.29M | -44.06M | -67.04M |
| Investing | -83.99M | -70.55M | 12.23M | -74.22M | -57.99M |
| Financing | 81.22M | 101.93M | 107.98M | 108.42M | 108.71M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -10.29M | -34.81M | -23.71M | -67.6M | -92.18M |
| Investing | -125k | -42k | -4.2M | -70.55M | -39.43M |
| Financing | -137k | 85.29M | 53.88M | 101.93M | 133.54M |
| Market Cap | 1.93B |
| Price to Earnings Ratio | -20.09 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 42.22 |
| Price to Book Ratio | 18.97 |
| Dividend Yield | - |
| Shares Outstanding | 44.43M |
| Average Volume (1 week) | 1.04M |
| Average Volume (1 Month) | 1.31M |
| 52 Week Change | 548.36% |
| 52 Week High | 50.78 |
| 52 Week Low | 6.70 |
| Spread (Intraday) | 4.83 (10.1%) |
| Company Name | Vera Therapeutics Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://veratx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
